Litcius/Paper detail

Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology–KROG/RTOG 1119 Phase 2 Randomized Trial

In Ah Kim, Kathryn Winter, Paul W. Sperduto, Jennifer F. De Los Santos, David M. Peereboom, Tomi Ogunleye, Daniel Boulter, Joel Fritz, Kwan Ho Cho, Kyung Hwan Shin, Imran Zoberi, Serah Choi, Joshua D. Palmer, Ben Liem, Yong Bae Kim, Bethany Anderson, Anupama W. Thakrar, Thierry Muanza, Michelle M. Kim, Doo Ho Choi, Minesh P. Mehta, Julia White

2023International Journal of Radiation Oncology*Biology*Physics18 citationsDOIOpen Access PDF

Topics & Concepts

LapatinibMedicineClinical endpointRadiosurgeryInternal medicineConcomitantOncologyBreast cancerRadiation therapyRandomized controlled trialAdverse effectMetastatic breast cancerCancerTrastuzumabBrain Metastases and TreatmentLung Cancer Research StudiesLung Cancer Treatments and Mutations
Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology–KROG/RTOG 1119 Phase 2 Randomized Trial | Litcius